An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?
-
Published:2018-06
Issue:6
Volume:122
Page:607-613
-
ISSN:0168-8510
-
Container-title:Health Policy
-
language:en
-
Short-container-title:Health Policy
Author:
Shafrin Jason,
Skornicki Michelle,
Brauer MichelleORCID,
Villeneuve Julie,
Lees Michael,
Hertel Nadine,
Penrod John R.,
Jansen Jeroen
Funder
Bristol-Myers Squibb
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献